Publications

Journal Article
Research Support, N.I.H., Extramural Review
Epublish 90 citations
Electronic publication date
January 1, 2021

View on Pubmed.gov 33091085 | View on doi.org 10.1371/journal...

A molecular understanding of alphavirus entry.

Search for publications in this journal PLoS Pathog - 16(10):e1008876

Abstract

Alphaviruses cause severe human illnesses including persistent arthritis and fatal encephalitis. As alphavirus entry into target cells is the first step in infection, intensive research efforts have focused on elucidating aspects of this pathway, including attachment, internalization, and fusion. Herein, we review recent developments in the molecular understanding of alphavirus entry both in vitro and in vivo and how these advances might enable the design of therapeutics targeting this critical step in the alphavirus life cycle.

References

Virology. 2006 Jan 5;344(1):38-47

Mini Rev Med Chem. 2008 Nov;8(13):1384-94

Rev Sci Tech. 1991 Sep;10(3):733-48

Antimicrob Agents Chemother. 2017 Feb 23;61(3):

Cited by 90 citations (total)

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Ly6C monocytes in the skin promote systemic alphavirus dissemination.

Electronic publication date April 1, 2024

Search for publications in this journal Cell Rep

Autumn C Holmes [...] Michael S Diamond et al.

Alphaviruses are mosquito-transmitted pathogens that induce high levels of viremia, which facilitates dissemination and vector transmission. One prevailing paradigm is...

Journal Article Review

Pathogenicity and virulence of chikungunya virus.

Electronic publication date September 2, 2024

Search for publications in this journal Virulence

Wesley Freppel [...] Lara J Herrero et al.

Chikungunya virus (CHIKV) is a mosquito-transmitted, RNA virus that causes an often-severe musculoskeletal illness characterized by fever, joint pain, and...

Conflict of interest statement

M.S.D. is a consultant for Inbios, Vir Biotechnology, NGM Biopharmaceuticals, and on the Scientific Advisory Board of Moderna. The Diamond laboratory has received unrelated funding under sponsored research agreements from Vir Biotechnology, Moderna, and Emergent BioSolutions.

MeSH

Specialties